NCT07631429

Brief Summary

This study investigates whether Body Roundness Index (BRI), an anthropometric measure derived from waist circumference and height, can predict mortality in adult intensive care unit (ICU) patients. BRI captures central adiposity and body fat distribution more accurately than Body Mass Index (BMI). In this prospective multicenter cohort study, BRI will be measured at ICU admission and its association with ICU mortality, 28-day mortality, hospital mortality, mechanical ventilation duration, ICU length of stay, and acute kidney injury will be evaluated. The predictive performance of BRI will also be compared with BMI.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
550

participants targeted

Target at P75+ for all trials

Timeline
16mo left

Started Aug 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 8, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

June 8, 2026

Status Verified

June 1, 2026

Enrollment Period

1 year

First QC Date

June 1, 2026

Last Update Submit

June 5, 2026

Conditions

Keywords

Body Roundness IndexBRIICU mortalityCritical illnessAnthropometric measuresCentral adiposityBMIObesity paradoxWaist circumference

Outcome Measures

Primary Outcomes (1)

  • ICU Mortality

    Death occurring during ICU stay, assessed from admission to ICU discharge or death, whichever comes first.

    From ICU admission to ICU discharge or death, up to 28 days.

Secondary Outcomes (5)

  • 28-Day Mortality

    28 days from ICU admission.

  • Hospital Mortality

    From ICU admission to hospital discharge or death, up to 90 days.

  • Mechanical Ventilation Duration

    From ICU admission to ICU discharge, up to 28 days.

  • ICU Length of Stay

    From ICU admission to ICU discharge, up to 28 days.

  • Number of Participants with New Acute Kidney Injury (KDIGO Stage ≥2)

    From ICU admission to ICU discharge, up to 28 days.

Study Arms (1)

Adult ICU Patients

Adult patients (≥18 years) admitted to the intensive care unit with an expected stay of ≥24 hours. Waist circumference and height are measured within 24 hours of admission to calculate Body Roundness Index (BRI) and BMI. Patients are followed for ICU mortality, 28-day mortality, hospital mortality, mechanical ventilation duration, ICU length of stay, and acute kidney injury (KDIGO stage ≥2). No intervention is applied; this is a prospective observational cohort.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients admitted to the intensive care units of participating tertiary care centers in Turkey. Enrollment will be conducted prospectively across multiple centers following ethics committee approval at each site.

You may qualify if:

  • Age ≥18 years
  • ICU admission with expected stay ≥24 hours
  • Waist circumference and height measurable within 24 hours of admission

You may not qualify if:

  • Age \<18 years
  • ICU stay \<24 hours
  • Missing or unmeasurable anthropometric data (e.g., severe edema, abdominal wound, morbid obesity precluding measurement)
  • Pregnancy
  • Readmission (only first ICU admission included)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ondokuz Mayis University, School of Medicine

Samsun, Atakum, 55002, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Critical IllnessObesityOverweightObesity, Abdominal

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and Symptoms

Central Study Contacts

Özkul Yilmaz Çolak, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
28 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Department of Internal Medicine, Division of Intensive Care, Ondokuz Mayıs University Faculty of Medicine

Study Record Dates

First Submitted

June 1, 2026

First Posted

June 8, 2026

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

June 8, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying published results will be made available upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 6 months after primary results publication, available for 2 years.
Access Criteria
Researchers who provide a methodologically sound proposal. Requests should be directed to the corresponding author. Data will be shared after signing a data access agreement.

Locations